Webinar: Accelerate PK/PD Insights with AI in Clinical Trials
PK/PD teams live in the details such as pulling dose/exposure tables, calculating Cmax and AUC, interpreting half-life, clearance, and safety profiles. When this data stays buried in clinical trial PDFs, it can:
Delay competitive assessments by 1 - 2 weeks
Push back dose and regimen decisions, which can delay trial starts by months
Give competitors first access to trial sites, patients cohorts, and regulatory momentum
In CNS or oncology, even a 2–3 day delay can cost millions or force late market entry. What if you could find that competitive PK/PD intel in minutes? Consider a new CNS drug: to gauge its prospects, you need to know how similar drugs crossing the blood–brain barrier are performing. That critical intel is out there in clinical trial reports and publications, but it’s buried in PDFs and unstructured tables. To learn how AI-powered PK/PD data extraction can get you a newer intel faster, we invite you to our upcoming webinar “AI-powered Insights from PK/PD Clinical Trial Data.” This live session will include a real-time demo of Polly Xtract and a discussion with experts on applying multi-agent AI in drug development. You will discover how teams are achieving 4× faster data curation and turning unstructured trial data into AI-powered insights. Register now to request your invite.